abstract |
The present invention pertains to: a novel p62 ligand compound or a stereoisomer, solvate, hydrate, or prodrug thereof; and a pharmaceutical or food composition containing same as an active ingredient for preventing or treating protein abnormality disorders. A p62 ligand compound according to the present invention can be useful as a pharmaceutical composition for preventing, alleviating, or treating various protein abnormality disorders by activating intracellular autophagy and selectively removing proteins, organelles, and coagulants in the body. |